‘Scientists have revealed how gene mutations known to cause the formation of certain inherited migraines target a cellular process involved in brain cell communication, furthering the possibility of new treatment opportunities.

Researchers at the McGill University Health Centre (MUHC) in Canada have investigated a debilitating hereditary form of migraine which is accompanied by visual impairments known as auras.

The study shows that specific genotypes can damage the operation of a tiny cellular mechanism known as the sodium pump (the sodium/potassium ATPase enzyme), reducing its efficiency.’

Read more at New hope for migraine sufferers

Recent Entries

• Sigma Pharmaceuticals year profit rises 27 pct
• South African citizens cheap drug guinea pigs
• Two drugs test victims face a year in coma
• Can drug companies improve their reputation?
• Pfizer Sees 40 Percent Rise in 2006 Net on Cost Cuts
• Pfizer’s Forecast Disappoints
• Pharmaceutical RFID Adoption Stalls
• Inhalable Drug Might Bring Sigh Of Relief To Diabetes Patients
• GlaxoSmithKline unveils best results since merger
• Pfizer Sues Teva, Sandoz Over Zithromax

This entry was posted on Friday, July 29th, 2005 at 2:29 am and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.